Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mesoblast Limited (MESO) vs Opendoor Technologies Inc (OPEN) Price & Performance

Mesoblast LimitedTrade
Opendoor Technologies IncTrade

Price performance (Past 24H)

Key statistics

Mesoblast Limited vs Opendoor Technologies Inc — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.16B), while Opendoor Technologies Inc trades at $3.58 (market cap $3.36B). The key difference: Opendoor Technologies Inc is the larger of the two by market cap, and Mesoblast Limited is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals.

MESOOPEN
Market Cap
$2.16B$3.36B
Sector
TechnologyReal Estate
52-Week High
$20.96$10.52
52-Week Low
$12.88$2.31
Enterprise Value
$2.17B$4.43B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mesoblast Limited

MESO trades at $15.94, up 2.05% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Ryoncil net revenues of $36 million for Q2 2026 (GlobeNewsWire, July 29, 2026), showing commercial traction, yet fundamentals reveal a net loss of -$102.14 million in 2025 with a negative net margin. Valuation metrics include a P/S of 30.52 and P/B of 3.76, indicating high growth expectations.

Outlook hinges on Ryoncil's expansion and pipeline progress, but risks include sustained losses and regulatory hurdles. Analysts are cautiously optimistic with 45% buy ratings, yet the stock faces volatility from earnings misses and high cash burn.

Opendoor Technologies Inc

Opendoor Technologies (OPEN) trades at $3.485, up 1.16% on the day, but remains in a bearish technical trend with weak fundamentals. Revenue has declined from $15.6B in 2022 to $4.37B in 2025, with persistent net losses and a negative net income margin of -46.74%. Recent Q2 2026 earnings missed expectations, and cash flow volatility adds to operational challenges. The stock faces headwinds from a sluggish housing market and high interest rates, as reflected in negative analyst sentiment and a consensus price target of $3.58.

The outlook for OPEN is cautious due to ongoing losses, competitive pressures, and macroeconomic uncertainty. While the low P/S ratio of 0.95 may attract value seekers, significant execution risk and debt levels pose threats. Investor sentiment is predominantly bearish, with 65% of analysts rating Hold. Recovery hinges on sustainable margin improvement and housing market stabilization, but near-term volatility is expected.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO

About Opendoor Technologies Inc

Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.

Read more on OPEN